ProKidney Corp - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: ProKidney Corp - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: ProKidney Corp - Ordinary Shares - Class A
Rating: 1.87908325
Author: Trendlyne DVM scores

about

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its produc...

2.62 -0.10 (-3.68%)

63.25% Fall from 52W High

785.4K

XNAS Volume

XNAS 25 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.8 / 100

Technically Bullish

74.3 / 100

1Yr Price target upside is 123%

6 analysts

ProKidney Corp Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ProKidney Corp - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its produc...

63.25% Fall from 52W High

SWOT Analysis

ProKidney Corp Ordinary Live Price Chart